journal article·2019-05-28Open access

Cross-Correlative Single-Cell Analysis Reveals Biological Mechanisms of Nanoparticle Radiosensitization

Tyron Turnbull, Michael Douglass, Nathan H. Williamson, Douglas Howard, Richa Bhardwaj, Mark Lawrence, David J. Paterson, Eva Bezak, Benjamin Thierry, Ivan M. Kempson

ACS Nano· Volume 13· Issue 5

Abstract

Nanoparticle radiosensitization has been demonstrated well to enhance the effects of radiotherapy, motivate the improvement of therapeutic ratios, and decrease morbidity in cancer treatment. A significant challenge exists in optimizing formulations and translation due to insufficient knowledge of the associated mechanisms, which have historically been limited to physical concepts. Here, we investigated a concept for the role of biological mechanisms. The mere presence of gold nanoparticles led to a down-regulation of thymidylate synthase, important for DNA damage repair in the radioresistant S-phase cells. By developing a cross-correlative methodology to reveal probabilistic gold nanoparticle uptake by cell sub-populations and the associated sensitization as a function of the uptake, a number of revealing observations have been achieved. Surprisingly, for low numbers of nanoparticles, a desensitization action was observed. Sensitization was discovered to preferentially impact S-phase cells, in which impairment of the DNA damage response by the homologous recombination pathway dominates. This small but radioresistant cell population correlates with much greater proliferative ability. Thus, a paradigm is presented whereby enhanced DNA damage is not necessarily due to an increase in the number of DNA double-strand breaks (DSBs) created but can be from a nanoparticle-induced impairment of the damage response by down-regulating repair proteins such as thymidylate synthase.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Radiation Therapy and Dosimetry · DNA Repair Mechanisms · Carcinogens and Genotoxicity Assessment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Future Industries Institute, University of South Australia, Mawson Lakes, South Australia 5095, Australia

Department of Medical Physics, Royal Adelaide Hospital, Adelaide, South Australia 5000, Australia

Department of Physics, University of Adelaide, Adelaide, South Australia 5005, Australia

Section on Quantitative Imaging and Tissue Sciences, NICHD, National Institutes of Health, Bethesda, Maryland 20892, United States

Department of Critical Care Medicine, Flinders University, Adelaide, South Australia 5042, Australia

Australian Synchrotron, Clayton, Victoria 3168, Australia

Funding

University of South Australia · Australian Research Council

References (58)

Show source-provided references
1. 10.1016/j.biomaterials.2015.05.03410.1016/j.biomaterials.2015.05.034 ↗
2. 10.1016/j.ejmp.2018.03.00410.1016/j.ejmp.2018.03.004 ↗
3. 10.1088/0031-9155/55/4/00210.1088/0031-9155/55/4/002 ↗
4. 10.1063/1.358991410.1063/1.3589914 ↗
5. 10.1259/bjr/5944883310.1259/bjr/59448833 ↗
6. 10.1088/1361-6560/aa623310.1088/1361-6560/aa6233 ↗
7. 10.1016/j.ejmp.2015.01.00610.1016/j.ejmp.2015.01.006 ↗
8. 10.1039/C5RA04013B10.1039/C5RA04013B ↗
9. 10.1016/j.ijrobp.2010.08.04410.1016/j.ijrobp.2010.08.044 ↗
10. 10.1186/s12951-016-0215-810.1186/s12951-016-0215-8 ↗
11. 10.1080/17435390.2017.131403610.1080/17435390.2017.1314036 ↗
12. 10.1039/C4TX00181H10.1039/C4TX00181H ↗
13. 10.18632/oncotarget.1871710.18632/oncotarget.18717 ↗
14. 10.1007/BF0004896510.1007/BF00048965 ↗
15. 10.1038/nrc326110.1038/nrc3261 ↗
16. 10.1016/j.ijrobp.2004.03.00510.1016/j.ijrobp.2004.03.005 ↗
17. 10.1038/srep3068910.1038/srep30689 ↗
18. 10.1667/RRAV07.110.1667/RRAV07.1 ↗
19. 10.1038/nnano.2011.19110.1038/nnano.2011.191 ↗
20. 10.1088/0957-4484/20/37/37510110.1088/0957-4484/20/37/375101 ↗
21. 10.1021/acsami.8b0020710.1021/acsami.8b00207 ↗
22. Curtin N. J. · Cancer Res. · 1991 · 51 · 2346
23. 10.1038/nrclinonc.2014.5110.1038/nrclinonc.2014.51 ↗
24. 10.1016/S1535-6108(04)00080-710.1016/S1535-6108(04)00080-7 ↗
25. Johnston P. G. · Cancer Res. · 1995 · 55 · 1407
26. 10.1038/sj.bjc.660579310.1038/sj.bjc.6605793 ↗
27. 10.1159/00006380410.1159/000063804 ↗
28. 10.1016/j.biomaterials.2014.10.06310.1016/j.biomaterials.2014.10.063 ↗
29. 10.1080/15257770.2014.89212710.1080/15257770.2014.892127 ↗
30. 10.1200/JCO.2007.11.528710.1200/JCO.2007.11.5287 ↗
31. 10.1038/s41598-017-18304-y10.1038/s41598-017-18304-y ↗
32. 10.1021/acsami.7b0111210.1021/acsami.7b01112 ↗
33. 10.1088/0957-4484/27/21/21510110.1088/0957-4484/27/21/215101 ↗
34. 10.1021/nn502356f10.1021/nn502356f ↗
35. 10.1038/nprot.2015.01610.1038/nprot.2015.016 ↗
36. 10.1039/c3an01406a10.1039/c3an01406a ↗
37. 10.1021/nn403118u10.1021/nn403118u ↗
38. 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;210.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2 ↗
39. 10.1016/j.jprot.2011.11.00210.1016/j.jprot.2011.11.002 ↗
40. 10.1039/C7LC00546F10.1039/C7LC00546F ↗
41. 10.1002/cyto.99001030210.1002/cyto.990010302 ↗
42. Clark G. M. · Semin. Oncol. · 1988 · 15 · 20
43. 10.1042/BJ2008041310.1042/BJ20080413 ↗
44. 10.1038/nrm235110.1038/nrm2351 ↗
45. 10.1016/j.dnarep.2007.02.00610.1016/j.dnarep.2007.02.006 ↗
46. 10.1038/nrm120210.1038/nrm1202 ↗
47. 10.1371/journal.pone.006242510.1371/journal.pone.0062425 ↗
48. Sharda N. · 2002 · 1
49. 10.1118/1.59745810.1118/1.597458 ↗
50. Johns H. · 1983
51. Report of the High Energy Brachytherapy Source Dosimetry (HEBD) Working Group, August 2012. Dose Calculation for Photon-Emitting Brachytherapy Sources with Average Energy Higher than 50 keV: Full Report of the AAPM and ESTRO. American Association of Physicists in Medicine: College Park, MD.
52. 10.1021/ja00904a00110.1021/ja00904a001 ↗
53. 10.1166/jnn.2015.1032110.1166/jnn.2015.10321 ↗
54. 10.1039/C4NR02100B10.1039/C4NR02100B ↗
55. 10.1021/la301390u10.1021/la301390u ↗
56. Paterson, D., de Jonge, M. D.; McKinlay, J.; Starritt, A.; Kusel, M.; Ryan, C. G.; Kirkham, R.; Moorhead, G.; Siddons, D. P. The X-Ray Fluorescence Microscopy Beamline at the Australian Synchrotron, AIP Conference Proceedings 2011; pp 219–222.10.1063/1.3625343 ↗
57. 10.1021/acs.analchem.5b0318310.1021/acs.analchem.5b03183 ↗
58. 10.1017/S088571561700071910.1017/S0885715617000719 ↗